BACKGROUND/OBJECTIVES: Dietary triacylglycerols (TAGs) containing palmitic acid in the sn-2 position might impair insulin release and increase plasma glucose. We tested this hypothesis by comparing postprandial responses to fats with varying proportions of palmitic acid in the sn-2 position. SUBJECTS/METHODS: Using a crossover-designed randomized controlled trial in healthy men (n = 25) and women (n = 25), we compared four meals on postprandial changes in glucose (primary outcome), insulin, C-peptide, glucose, glucose-dependent insulinotropic polypeptide (GIP) and polypeptide YY (PYY) concentrations. The meals provided 14 g protein, 85 g carbohydrate and 50 g test fat, supplied as high oleic sunflower (HOS) oil (control), palm olein (PO), interesterified palm olein (IPO) and lard containing 0.6, 9.2, 39.1 and 70.5 mol% palmitic acid at sn-2, respectively. RESULTS: No differences in plasma glucose, insulin and C-peptide response between meals were found. GIP release was lower (P o 0.001) for IPO and lard compared with HOS and PO meals; the maximal increments (geometric mean and 95% confidence interval) for HOS, PO, IPO and lard were 515 (468, 569), 492 (448, 540), 398 (350, 452) and 395 (364, 429) ng/l, respectively. There was a trend for the postprandial increase in PYY to be lower in women on the IPO and lard meals than those on the HOS and PO meals. CONCLUSIONS: Dietary TAGs with an increased proportion of palmitic acid in the sn-2 position do not have acute adverse effects on the insulin and glucose response to meals in healthy men and women, but they decrease GIP release.
INTRODUCTION
Palmitic acid (16:0), the most abundant saturated fatty acid (SFA) in the diet and synthesized de novo, is confined to the sn-1 and sn-3 positions of triacylglycerols (TAG) in most vegetable oils, whereas in animal fats, such as lard, it is present mainly in the sn-2 position. High-melting-point fats are essential for the production of certain foods such as margarines and bakery products. Traditionally animal fats or partially hydrogenated vegetable fats rich in trans fatty acids were favoured for this purpose. However, trans fats have been associated with increased risk of cardiovascular disease and there is increased consumer demand for products free of animal fats. Therefore, vegetable fats modified by interesterification are now widely used to supply fats with the functional properties required by the food-processing industry. Interesterification alters the distribution of fatty acids within the TAG molecule. Commercially, enzyme-directed interesterification was first applied to palm oil fractions to improve the digestibility of fat for infant formulas. However, enzymatic and chemically catalysed interesterification is now widely used in the food industry for the production of specialized fats used for margarine manufacture and for bakery applications. 1 The rationale behind interesterification is to mimic fats, such as lard, that have melting points in the range 30-38°C. The process is typically applied to mixtures of liquid vegetable oils and a 'hard stock' (either a palm oil fraction, rich in palmitic acid, or a fully hydrogenated soybean oil, rich in stearic acid). There have been few studies on the health effects of interesterified fats. [2] [3] [4] Sundram et al. 3 claimed that an interesterified fat made of fully hydrogenated soybean oil impaired insulin release and increased postprandial glucose concentrations. However, in a short-term feeding study, Berry et al. 2 found no differences between randomized and native shea butter (a natural rich source of stearic acid) on postprandial plasma glucose and insulin responses. Hayes and Pronczuk 5 have also expressed caution over the use of interesterified palm oil to replace trans fats. Indeed, in an acute test meal study comparing randomized super palm olein (PO) with native PO, Berry et al. 6 found a small difference in postprandial insulin but not glucose responses. The present study was designed to test the hypothesis that an increased proportion of palmitic acid in the sn-2 position had an acute adverse effect on insulin release and glucose disposal.
There are no obvious mechanisms to explain how TAG structure might affect insulin and glucose homeostasis. However, on the basis of a previous observation 7 that cholecystokinin release was suppressed by medium-chain triglycerides, we postulated that TAG structure might influence the release of gut hormones involved in promoting insulin secretion and energy sensing. Glucose-dependent insulinotropic polypeptide (GIP) is released from the small intestinal K-cells in response to long-chain fatty acids. 8 The primary target of GIP action is the pancreas, where it promotes insulin secretion, 9 but it also has an anabolic role in adipose tissue and in promoting fat deposition. 10 ,11 SFA appears 1 Diabetes and Nutritional Sciences Division, School of Medicine, King's College London, London, UK and to be less potent than monounsaturated fatty acids in inducing GIP release, when introduced into the small intestine. However, there is limited evidence to show that meals of different fatty acid composition or TAG structure influence GIP release. 12, 13 Polypeptide YY (PYY) is secreted from intestinal L-cells in response to the presence of luminal nutrients as well as neuronal stimulation and is believed to play an important role in energy sensing. 14, 15 However, peak plasma PYY concentrations increase in line with the energy content of the meal, and therefore, as dietary fat is the most energy-dense macronutrient, it plays an important role in stimulating PYY release. Whether palmitic and oleic acids have different effects on PYY release is uncertain. 16 We hypothesized that interesterification of PO to make its physical properties more similar to lard would alter insulin secretion and glucose homeostasis and might influence the release of gut hormones. We have previously reported the changes in postprandial lipids observed in such a study. 17 Here we report the findings of the present randomized controlled trial of standardized high-fat test meals that demonstrate that altering the molecular structure without changing the fatty acid composition acutely decreases GIP release and possibly influences PYY release.
MATERIALS AND METHODS Subjects
Fifty healthy adult subjects (25 men and 25 women, aged 18-45 years; body mass index 20-35 kg/m 2 , normotensive BPo140/90 mm Hg) were recruited from among the staff and students of King's College London (UK) and the Maastricht University (Netherlands). This study (ISRCTN20774126) was conducted according to the guidelines laid down in the Declaration of Helsinki and all procedures involving human subjects were approved by the relevant ethics committees in the UK (NREC 08/H1101/122) and the Netherlands (MEC 09-3-009). Recruitment onto the trial was initiated in May 2009 and completed in December 2009. Written informed consent was obtained from all subjects. The exclusion criteria included a history of coronary heart disease, >20% risk of developing cardiovascular disease over the next 10 years, diabetes mellitus, cancer, pancreatitis, liver or renal disease, use of lipid or blood pressure-lowering medications, history of substance misuse or alcoholism, plasma cholesterol>7.8 mmol/l, plasma TAG>3 mmol/l, and plasma glucose>7 mmol/l. All the participants attended a screening visit in a fasted state, at one of the participating centres. Height, weight, waist circumference and blood pressure were measured, and fasting glucose, plasma lipid concentrations, liver function and haematology were confirmed to be within normal limits prior to entry into the study.
Study design
A randomized double-blind cross-over design was used to compare four test meals. A Latin square design was used to allocate the subjects to a treatment order for the four test meals, and each test meal protocol was separated by at least 1 week. No attempt was made to control for menstrual cycle in female participants, as any effect would be balanced out by the orthogonal design. The random allocation of treatment sequence was done using a computer program and was blinded for both the investigators and the study participants. Each test meal consisted of a muffin and a milkshake and provided 3.54 MJ (846 kcal), 14 g protein, 85 g carbohydrate and 50 g test fat. The four test fats used were: lard (cooking fat of porcine origin, Sainsbury PLC, London, UK), HOS oil (Archer Daniel Mills Pura Ltd, Erith, UK), native palm olein (iodine value 56) (Archer Daniel Mills Pura Ltd) and the same palm olein (iodine value 56) that had been interesterified (Unimills BV, Zwijndrecht, Netherlands). The test fats were baked into muffins, labelled with a code and stored frozen until consumed. The compositions of the test meals have been described elsewhere. 17 The compositions and melting characteristics of the test fats are shown in Table 1 . Power calculations were based on 48 subjects completing the study in order to detect a 0.5 s.d. difference between means of incremental area under the curve (iAUC) between 0 and 120 min for plasma glucose with 90% power and 1% significance. The study had the power to detect a 0.7 s.d. difference between means of iAUC for each gender at 90% power and 1% significance for 24 subjects. Changes in plasma insulin and C-peptide were secondary outcomes. Gut peptide concentrations were regarded as exploratory outcomes.
On the day preceding each test meal, participants were asked to refrain from strenuous exercise and to avoid alcohol and foods high in fat. A standardized low-fat meal (2-3 MJ containing o10 g fat) was provided to be consumed as an evening meal before 2200 h. Thereafter, no food or drink except for water was consumed until the participants attended a metabolic facility between 0800 and 1000 h the following morning. A Venflon Pro 22 GA cannula (Beckton-Dickinson, Oxford, UK; cat. no. 393202) was inserted into the forearm (antecubital vein) and blood collected immediately by syringe was dispensed into appropriate uncapped blood collection vacutainers. The test meal was consumed within 10 min and further venous blood samples were collected at 15, 30, 60, 90, 120, 150, 180, 240, 300, 360, 420 and 480 min following the test meal. Participants had access to water to sip regularly (up to 750 ml) over the 8 h. The data reported here are confined to the first 3 h.
Analytical methods
Samples for plasma glucose concentration analysis were collected into fluoride oxalate vacutainers and kept on ice for a maximum of 15 min, before being centrifuged. Plasma was collected and stored at − 40°C until analysed using an enzymatic glucose assay (ILAB, Instrumentation Laboratories, Warrington, Cheshire, UK) on an ILAB 650 analyzer. Insulin and C-peptide were collected into serum separator tubes and allowed to stand at room temperature for a maximum of 30 min, followed by centrifugation and serum collection for storage at − 80°C. Two-site sandwich and chemiluminescence immunoassays were used to determine insulin and C-peptide concentrations, respectively (Siemens Medical Solutions Diagnostics Europe Ltd., Berks, UK). Samples for GIP, glucagonlike peptide-1 and total PYY analysis were collected into 4 ml EDTA vacutainers containing 100 μl of trasylol (10 000 KIU/ml, Nordic Pharma Ltd., Reading, UK) and kept on ice up to 15 min, followed by centrifugation and plasma storage at − 80°C until analysed using a sandwich ELISA and a radioimmunoassay kit (Linco Research, St Charles, MO, USA) respectively. Abbreviations: MP, melting point determined by differential scanning calorimetry; sn-2, stereospecific position 2 of triacylglycerol. Solid fat content determined by nuclear magnetic resonance. The analytical methods have been previously described.
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Statistical analysis
Incremental areas under the curves (iAUC 0-120 min ) over the first two hours were calculated with GraphPad Prism (version 5.01; GraphPad, La Jolla, CA, USA) using the trapezoid rule. Indices of insulin sensitivity and beta-cell function were estimated using the HOMA2 software (http://www.dtu.ox.ac. uk/homa). The ratio iAUC insulin/iAUC glucose over the first 2 h following the test meal was calculated as a measure of insulin sensitivity following the meal. The distributions of data were checked for normality using a Shapiro-Wilk's normality test and logarithmic transformations were used where appropriate. Statistical analysis of the data was carried out with repeated-measures analysis of variance, with meal and time as within-subject factors and gender as a between-subject factor, using SPSS PC version 20 (SPSS Software, IBM, Armonk, NY, USA). Comparisons between groups were made using a Bonferonni correction for six comparisons and correlations were made using the partial correlations module of SPSS.
RESULTS
All participants (n = 50) completed the study and their details are shown in Table 2 . Blood samples were missing on some time points and complete sets of data were available on 48 subjects for all diets for the primary outcome (iAUC 0-120 min ). The results for plasma glucose, insulin and C-peptide are shown in Figures 1-3 .
The responses between meals were remarkably similar and there were no statistically differences between meals, nor were there any differences in the ratio insulin AUC0-120 min /glucose AUC0-120 min between treatments. Although there were no treatment-related effects, there were significant time x gender interactions for plasma glucose (P o0.0001), insulin (P = 0.005) and C-peptide (P = 0.001). Women showed smaller increases in plasma glucose compared with the men in the first hour after the meal (Supplementary Table 1 ) and consistently greater early-phase increments in plasma insulin and C-peptide compared with the men (Supplementary Tables 2 and 3 ). For all meals combined the glucose AUC0-120 min was 44% lower (95% confidence interval − 73, − 15) and the insulin AUC0-120 min was 29% higher (95% confidence interval 5, 54) in women compared with men. A highly statistically significant meal x time interaction (P o 0.0001) for the increase in plasma GIP was noted and this remained after adjusting for the fasting-value GIP (P = 0.002). There were no interaction effects of gender. The postprandial increase in plasma GIP was lower following the lard and IPO meals compared with the HOS and PO meals ( Figure 4) ; the maximal increments (geometric mean and 95% confidence interval) for HOS, PO, IPO and lard were 515 (468, 569), 492 (448, 540), 398 (350, 452) and 395 (364, 429) ng/L, respectively. Values obtained for glucagon-like peptide-1 appeared to be unreliable because of not adding dipeptidyl peptidase at the time of collection in addition to aprotinin and so are not reported.
There was a significant gender x meal x time interaction (P = 0.043) for the postprandial changes in PYY ( Figure 5) , with women showing greater increments in the first 30 min following the meal, particularly following the PO and HOS meals. No other statistically significant differences were noted. 
DISCUSSION
No effect of IPO compared with PO on postprandial glucose (the primary outcome) was found in agreement with reports from smaller studies. 6, [18] [19] [20] Our failure to demonstrate that SFA meals increase insulin secretion compared with monounsaturated fatty acids is at variance with two studies by Lopez et al., 21, 22 who claimed a substantial greater postprandial insulin increase and reduced insulin sensitivity following meals high in SFA provided by butter compared with monounsaturated fatty acids supplied by olive oil: the first study was conducted in 14 healthy men and the second in 14 men with hypertriglyceridaemia. In both studies by Lopez et al. the amount of fat provided in the test meal was about 80% greater than in the present study. Furthermore, the fats were provided in different forms: butter, which is an emulsion, vs olive oil; the meal only contained 20 g carbohydrate as opposed to 85 g in the present study, much less than the amount used in a standard glucose tolerance test, which uses 75 g glucose. Similar criticisms can be levelled at the studies of Thomsen et al., 13 who tested fats with 100 g butter vs 80 g olive oil with virtually energyfree soup. The test meal used in the present study (a muffin and a milkshake) provided a similar amount of energy to that used by Lopez et al., but had a more realistic fat load (50 g, 55% energy), which is at the upper end of the amount likely to be consumed in a single mixed meal and is more representative of the food that people eat on a daily basis.
The most salient finding of the present study was a substantially lower secretion of GIP following the IPO-and lard-containing meals compared with the PO and HOS meals. IPO had an identical fatty acid composition to PO but a different TAG structure. The decreased release of GIP after IPO intake compared to PO intake indicates that TAG structure rather than fatty acid composition determines the effect. It is likely, therefore, that the lower GIP response following IPO vs PO can be explained by the higher proportion of palmitic acid in the sn-2 position especially as the lard, which contains almost all of its palmitic acid in the sn-2 position, showed the same effect. The initial GIP response occurred very rapidly, and by 30 min a difference between meals was evident. It is possible that the physical properties of the fats play a role in promoting GIP release. PO had physical properties closer to HOS and these two oils would be in the liquid phase at body temperature. This may favour formation of micelles and initiate lipolysis, thereby stimulating K-cells, which are primarily located in the duodenum, to initiate release of GIP to a greater Figure 2 . Plasma insulin concentrations (geometric mean (GM) with 95% confidence interval (CI)) in men (n = 25) and women (n = 25) following test meals containing 50 g of test fat from high oleic sunflower oil-control (■), palm olein (▲), interesterified palm olein (▼) and lard (•). Deviations from fasting values were analysed by repeated-measures analysis of variance (ANOVA), with the four meals and times (0-8 h) as factors; the meal x times interaction was not significant. The inset shows incremental area under curve (iAUC 0-120 min ) values for plasma insulin (GM with 95% CI) up to 120 min (n = 25 men; n = 23 women), which were analysed by repeated-measures ANOVA and found to be not statistically significant. extent than after lard or IPO consumption, which would first need to melt, but this would be expected to occur rapidly within 10-15 min. However, such an effect would be expected to result in delayed release of GIP following IPO and lard meals rather than inhibition of GIP secretion. IPO and lard have higher melting points than PO, but are both well digested, especially as the proportion of palmitic acid in the sn-2 position is greater. The 2-mono-oleyl-glycerol would be generated by the action of pancreatic lipase on HO and PO meals, whereas it would be mainly 2-mono-palmitolyl glycerol following IPO and lard meals. This was confirmed by demonstrating that the fatty acid at the sn-2 position was retained in that position in chylomicrons TAG. 17 Recent research indicates that 2-monoacylglycerols may act as signalling molecules in the endocanniboid signalling pathway. 23 It is possible therefore that they may be involved in the regulation of GIP secretion.
Few studies have compared the effects of different fats on PYY secretion and our comparison involves the largest number of participants so far reported. Cooper et al. 24 conducted a 2 × 2 factorial designed crossover study in eight healthy males comparing diets that were high either in monounsaturated fatty acids or in SFA, and/or in exercise or sedentary conditions. They found that exercise increased PYY, indicating a role of physical stimulation of the gut, but reported no effect of fat composition. We noted a tendency for PYY release to be slightly lower following the sn-2-rich meals than the HOS and PO meals, especially in the female participants, that is, in the same direction as the change in GIP. This is the first study to show clear-cut differences in the pattern of GIP secretion between palmitic acid-rich fats with different TAG structures. Both lard and IPO reduced the release and this effect is probably not due to melting point effects as lard has a melting point of below body temperature. The exact mechanisms that lead to the secretion of GIP, PYY and other gut hormones such as CCK, glucagon-like peptide-1 and oxyntomodulin are uncertain. CCK and glucagon-like peptide-1 are likely to be released via the direct interaction of nutrients and nutrient receptors within the gastrointestional tract in addition to neuronal pathways. Our findings indicate that the physical structure of TAG may influence the interaction of fat with nutrient receptors, with oleic acid in the sn-2 position enhancing the release of GIP. The significance of the changes in GIP on insulin secretion is uncertain because there was no evidence of the impact of any change on insulin secretion as indicated by changes in C-peptide concentrations. However, animal models suggested that increase in GIP production promotes fat storage and obesity. 25 Enteroendocrine signalling may also effect cell signalling via the vagus nerve. 26 The emerging evidence 27 that changes in levels of these peptides are associated with the rapid resolution of type 2 diabetes in patients following Roux en-Y gastric bypass surgery underscores the importance of elaborating the mechanism involved.
The strength of this study is that it was conducted double-blind, statistically well-powered and included both men and women. A limitation is that the participants were healthy and not a crosssection of the general population, where obesity is prevalent. The findings may also not be generalizable to people with prediabetes/type 2 diabetes, who have impaired incretin responses. 28 Another limitation is that this was an acute study and it is possible that adaptation to the diet occurs. 9 In conclusion, this study found no evidence that increasing the proportion of palmitic acid in the sn-2 position acutely affects insulin release and plasma glucose, but it does impair GIP secretion in healthy young men and women. This study indicates that there may be subtle effects of changing TAG structure on the release of gut hormones. Future studies should consider whether the differences in GIP secretion observed persist in the longer term. 
